Completed PHASE1 INTERVENTIONAL 2-arm NCT01849991

Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic

Sponsor: The University of Texas Health Science Center, Houston

Interventions Lactobacillus reuteri Placebo

Updated 6 times since 2017 Last updated: Jan 26, 2018 Started: Sep 30, 2013 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01849991, this PHASE1 trial focuses on Colic and Gastrointestinal and remains completed. Sponsored by The University of Texas Health Science Center, Houston, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Texas Health Science Center, Houston

Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States